NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

I spoke with Dave and he mentioned that it was on the advice of the SAB and the steering committee that they'd received some time ago that they add obtaining this data to the process.

Sentiment,

from the publication: "First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma."
(Published: 29 May 2018)

The mutation status of the IDH1 gene has not yet been investigated for this trial, as this factor was not included in trial designs a decade ago when this trial began. It will be collected and analyzed later, but is unlikely to explain the overall survival results, as the mutation associated with prolonged survival occurs in less than 10% of newly diagnosed glioblastoma patients [27].
https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1507-6